NCT07041983Enrolling by invitation
24-h Energy Expenditure and Anti-obesity Medication
Effects of Anti-obesity Medications on 24h Energy Metabolism and Body Composition in Patients With Obesity
Source: ClinicalTrials.gov · Last updated 5 May 2026
Brief summary (registry, in English)
This study investigates the long-term effects of anti-obesity medications (Semaglutide and Tirzepatide) on energy metabolism (24-hour energy expenditure and substrate oxidation) and body composition via Dual-energy X-ray absorptiometry (DXA)
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 30 (estimated)
- First submitted
- 28 May 2025
- Start date
- Jul 2025
- Primary completion date
- Jun 2026
- Lead sponsor
- University of Pisa
- Diseases
- Obesity
- NCT number
- NCT07041983
What you commit to
- Study type: Observational
- Planned participants: 30
- From Jul 2025 to the primary completion date, Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- psychiatric conditions impairing adherence, history of medullary thyroid cancer, pregnancy/lactation
- diabetes
Who the study is looking for
- Body mass index (BMI) \>= 30 kg/m² or \>= 27 kg/m² with at least one weight-related comorbidity and stable body weight (±2 kg in prior 3 months)
- informed consent, adherence to study protocol, negative pregnancy test and contraception use (if applicable), and absence of cardiovascular events or end-organ damage.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital of Pisa Coordinator of this site? Confirm its status | Pisa | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.